CAMPIONI, Diana; Bardi MA; CAVAZZINI, Francesco; TAMMISO, Elisa; Pezzolo E; PREGNOLATO, Emma; Volta E; CUNEO, Antonio; LANZA, Francesco, Cytogenetic and molecular cytogenetic profile of bone marrow-derived mesenchymal stromal cells in chronic and acute lymphoproliferative disorders, «ANNALS OF HEMATOLOGY», 2012, 91, pp. 1563 - 1577 [Scientific article]
Hübel K; Fresen MM; Apperley JF; Basak GW; Douglas KW; Gabriel IH; Geraldes C; Jaksic O; Koristek Z; Kröger N; Lanza F; Lemoli RM; Mikala G; Selleslag D; Worel N; Mohty M; Duarte RF., European Data on Stem Cell Mobilization with Plerixafor in Non-Hodgkin’s Lymphoma, Hodgkin’s Lymphoma and Multiple Myeloma Patients. A Subgroup Analysis of the European Consortium of Stem Cell Mobilization., «BONE MARROW TRANSPLANTATION», 2012, 47, pp. 1046 - 1050 [Scientific article]
Worel N; Apperley JF; Basak GW; Douglas KW; Gabriel IH; Geraldes C; Hübel K; Jaksic O; Koristek Z; Lanza F; Lemoli R; Mikala G; Selleslag D; Duarte RF; Mohty M., European data on stem cell mobilization with plerixafor in patients with nonhematologic diseases: an analysis of the European consortium of stem cell mobilization., «TRANSFUSION», 2012, 52, pp. 2395 - 2400 [Scientific article]
Basak G.W.; Wiktor Jedrzejczak W.; Apperley J.F.; Douglas K.W.; Gabriel I.H.; Geraldes C.; Hübel K.; Jaksic O.; Koristek Z.; Lanza F.; Lemoli R.; Mikala G.; Selleslag D.; Worel N.; Mohty M.; Duarte R.F., Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSF., «BONE MARROW TRANSPLANTATION», 2012, 47, pp. 1003 - 1005 [Scientific article]
LANZA, Francesco; CAMPIONI, Diana; MAURO, Endri; A. Pasini; RIZZO, Roberta, Immunosuppressive properties of mesenchymal stromal cells, in: Advances in Stem Cell Research, Totowa, Humana Press Inc., 2012, pp. 281 - 301 [Chapter or essay]
Preffer F.; Lanza F., Issue highlights -May 2012, «CYTOMETRY. PART B, CLINICAL CYTOMETRY», 2012, 82B, pp. v - vi [Scientific article]
Malard F.; Kröger N.; Gabriel I.H.; Hübel K.; Apperley J.F.; Basak G.W.; Douglas K.W.; Geraldes C.; Jaksic O.; Koristek Z.; Lanza F.; Lemoli R.M.; Mikala G.; Selleslag D.; Worel N.; Mohty M.; Duarte R.F., Plerixafor for autologous peripheral blood stem cell mobilization in patients previously treated with fludarabine or lenalidomide., «BONE MARROW TRANSPLANTATION», 2012, 18, pp. 314 - 317 [Scientific article]
Olivieri A.; Marchetti M.; Lemoli R.M; Tarella C.; Iacone A.; Lanza F.; Rambaldi A.; Bosi A., Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo italianoTrapianto di Midollo Osseo., «BONE MARROW TRANSPLANTATION», 2012, 47(3), pp. 342 - 351 [Scientific article]
Chabannon, C; Pamphilon, D; Vermylen, C; Lanza, F; Slaper-Cortenbach, I; Madrigal, A; Apperley, J, Ten years after the first inspection of a candidate European centre, an EBMT registry analysis suggests that clinical is improved when hematopoietic SCT is performed in a Jacie accredited program, «BONE MARROW TRANSPLANTATION», 2012, 47, pp. 15 - 17 [Scientific article]
ZAULI, Giorgio; Celeghini C; MELLONI, Elisabetta; VOLTAN, Rebecca; Ongari M; Tiribelli M; DI IASIO, Maria Grazia; Lanza F; SECCHIERO, Paola, The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status, «HAEMATOLOGICA», 2012, 97, pp. 1722 - 1730 [Scientific article]
Buzzi M.; Alviano F.; Campioni D.; Stignani M.; Melchiorri L.; Rotola A.; Tazzari P.; Ricci F.; Vaselli C.; Terzi A.; Pagliaro P.P.; Cuneo A.; Lanza F.; Bontadini A.; Baricordi O.R.; Rizzo R., Umbilical cord blood CD34(+)cell-derived progeny produces
human leukocyte antigen-G molecules with immuno-modulatory functions., «HUMAN IMMUNOLOGY», 2012, 73(2), pp. 150 - 155 [Scientific article]
Rizzo R.; Lanzoni G.; Stignani M.; Campioni D.; Alviano F.; Ricci F.; Tazzari P.L.; Melchiorri L.; Scalinci S.Z.; Cuneo A.; Bonsi L.; Lanza F.; Bagnara G.P.; Baricordi O.R., A simple method for identifying bone marrow mesenchymal stromal cells with a high immunosuppressive potential., «CYTOTHERAPY», 2011, 13, pp. 523 - 527 [Scientific article]
C. Fill; C. Finelli; M. Gobbi; G. Martinelli; I. Iacobucci; E. Ottaviani; L. Cocco; F. Matilde; A. Candoni; E. Simeone; M. Miglino; F. Lauria; M. Bocchia; M. Defina; C. Clissa; F. Lanza; P. Spedini; C. Skert; C. Bergonzi; M. Malagola; A. Peli; A. Turra; F. Cattina; C. Colombi; D. Russo, Azacitidine low-dose schedule in low-risk myelodysplastic syndromes. Clinical results of a multicenter phase II study, in: Abstracts of the 11th International Symposium on Myelodysplastic Syndromes (MDS), «LEUKEMIA RESEARCH», 2011, 35, pp. S84 - S85 (atti di: 11th International Symposium on Myelodysplastic Syndromes (MDS), EDINBURGH, 18-21 MAGGIO 2011) [Abstract]
CAMPIONI, Diana; LANZA, Francesco, Cellule mesenchimali stromali: caratterizzazione immunofenotipica e funzionale, «LETTERE GIC», 2011, 20, pp. 13 - 19 [Scientific article]
CAMPIONI, Diana; Lodolini V.; Gambetti; Miccoli M; Ferrari L.; Pasini AL; Monti M.; BRISTOT, Laura; CECONI, Claudio; FERRARI, Roberto; CUNEO, Antonio; LANZA, Francesco, Cellule staminali circolanti in pazienti con infarto miocardico, «BIOLOGI ITALIANI», 2011, 4, pp. 49 - 55 [Scientific article]
